The neurologists and neuroscientists behind every decision
Your manuscript is handled by named experts in clinical and translational neurology: a board of 18 researchers and clinicians across 8 countries, led by a subject Editor-in-Chief.
Editor-in-Chief
Zheng Jiang
Baylor College of Medicine, Houston, USA
Neural/retinal electrophysiology
Formerly: Research Associate in Neuroscience, Johns Hopkins University School of Medicine.
Editorial board members
Subject experts across epilepsy, neurodegeneration, stroke and neurovascular biology, neurotrauma and clinical neurophysiology. Each decision on your manuscript is signed by a named editor in the relevant field.
Joslin Diabetes Center (Harvard Medical School affiliate), Boston, MA, USA
Neurovascular biology and stroke
0009-0003-0279-4035
Farber Institute for Neuroscience, Thomas Jefferson University, Philadelphia, PA, USA
Spinal cord injury
Houston Methodist Research Institute, Houston, TX, USA
Neurodegeneration and DNA-damage repair
0000-0001-7333-8123
Kırşehir Ahi Evran University, Faculty of Medicine, Kırşehir, Turkey
Neurology / migraine
0000-0002-2367-1128
Oasi Research Institute IRCCS, Troina, Italy
Clinical neurophysiology and epilepsy
0000-0002-8358-0885
School of Medicine, Western Sydney University, Campbelltown, Australia
Neuroimmunology
0000-0001-8664-6918
University of Tennessee Health Science Center, Memphis, TN, USA
Stroke and neurovascular injury
Editors are listed as recorded by the journal. Board members join and rotate over time, so this page is kept current.
Have your work judged by experts in the field
A named, subject-matter board, Single-blind (double-blind on request) peer review, and a first decision in about three weeks. Read the guidelines, then submit.